$AKTX ripping +47% AH 🚀 🔹 Akari catching serious after-hours momentum as biotech traders pile in 📈 🔹 Company developing ADC cancer therapies using a novel R

$AKTX ripping +47% AH 🚀 🔹 Akari catching serious after-hours momentum as biotech traders pile in 📈 🔹 Company developing ADC cancer therapies using a novel RNA splicing modulator payload 🧬 🔹 Fresh catalyst: announced a $5.5M private placement to support its oncology pipeline 💰 🔹 Recent patent…